FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2301666318> ?p ?o ?g. }

• W2301666318 endingPage "S33" @default.
• W2301666318 startingPage "S33" @default.
• W2301666318 abstract "It has been well known that minimal residual disease (MRD) pre-conditioning has remarkable impact on disease-free survival (DFS) after allogeneic hematopoietic stem cell transplantation (HSCT) for patients with acute lymphoblastic leukemia, but the effect of MRD before transplant on the outcomes of allogeneic HSCT in acute myeloid leukemia (AML) is still unclear. In present study, the effect of MRD by flow cytometry (FCM) pre-conditioning on DFS after allogeneic HSCT in AML was investigated. Between April 2012 and December 2014, consecutive 168 patients with AML in CR1 who underwent allogeneic HSCT in our hospital were analyzed retrospectively. The median age was 23 (1.8 to 64) years old. Children (≤14 years) were 51 (30.4%) and adults (>14 years) were 117 (69.6%) cases. The median disease course was 8 (2-37) months. Cytogenetics in good-, intermediate-, high-risk were 40 (23.8%), 89 (53.0%), and 39 (23.2%) cases. Donor sources were identical sibling (IS) in 44 (26.2%), unrelated (UR) in 23 (13.7%), and haploidentical (HI) in 101 (60.1%) cases. Myeloablative conditioning regimens were administered with either busulfan (Bu) plus cyclophosphamide (Cy)/fludarabine (Flu)-based in 150 (89.3%) or TBI plus Cy/Flu-based in 18 (10.7%) patients. ATG was used in UR and HI transplant. Unmanipulated bone marrow (BM) and peripheral blood stem cells (PBSC) for IS and HI HSCT, and PBSC for UR transplant. Cyclosporine, short-term methotrexate, and mycophenolate mofetil were employed for GVHD prophylaxis. MRD in BM before conditioning was detected by FCM. MRD was 0% in 140 (83.3%), 0.01% to 0.1% in 3 (1.8%), 0.1% to 1% in 17 (10.1%), and 1% to 3% in 8 (4.8%) patients. With the median follow up 16 (6-39) months, two-year DFS was 81.6%. Two-year DFS after transplant for patients with AML was 52.9% vs 87.0% with or without MRD (p<0.0001). The levels of MRD has remarkable influence on DFS post-HSCT in AML (87.0% for MRD 0%, 66.6% for MRD 0.01% to 0.1%, 57.1% for MRD 0.1% to 1%, 28.5% for MRD1% to 3%, respectively (p<0.0001). Univariate analysis showed that DFS after HSCT in AML was not associated with patient age (children vs. adults, 86.3% vs. 80.0%, p=0.53), cytogenetics (good- vs. intermediate- vs. high-risk, 86.5% vs. 82.4% vs. 73.8%, p=0.62), donor source (IS vs. UD vs. HI, 87.0% vs. 84.8%vs. 77.8%, p=0.51), and conditioning regimen (Bu-based vs. TBI-based, 82.1% vs. 78.7%, p=0.92). Multivariate analysis indicated that MRD pre-HSCT was the only impact factor on DFS after transplant in AML (p=0.000). We have demonstrated that MRD pre-conditioning for patients with AML has significant impact on DFS after allogeneic HSCT but not patient age, cytogenetics, donor source and conditioning regimen. Allogeneic HSCT has attenuated the influence of cytogenetics on DFS in AML." @default.
• W2301666318 created "2016-06-24" @default.
• W2301666318 creator A5013836476 @default.
• W2301666318 creator A5018040730 @default.
• W2301666318 creator A5023095202 @default.
• W2301666318 creator A5035705032 @default.
• W2301666318 creator A5045773186 @default.
• W2301666318 creator A5054435108 @default.
• W2301666318 creator A5055344816 @default.
• W2301666318 creator A5065202324 @default.
• W2301666318 creator A5072543271 @default.
• W2301666318 creator A5075043769 @default.
• W2301666318 creator A5075391403 @default.
• W2301666318 creator A5085753584 @default.
• W2301666318 creator A5090366405 @default.
• W2301666318 date "2016-03-01" @default.
• W2301666318 modified "2023-09-26" @default.
• W2301666318 title "Minimal Residual Disease by Flow Cytometry Pre-Conditioning has Significant Impact on Disease-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia" @default.
• W2301666318 doi "https://doi.org/10.1016/j.bbmt.2015.11.301" @default.
• W2301666318 hasPublicationYear "2016" @default.
• W2301666318 type Work @default.
• W2301666318 sameAs 2301666318 @default.
• W2301666318 citedByCount "0" @default.
• W2301666318 crossrefType "journal-article" @default.
• W2301666318 hasAuthorship W2301666318A5013836476 @default.
• W2301666318 hasAuthorship W2301666318A5018040730 @default.
• W2301666318 hasAuthorship W2301666318A5023095202 @default.
• W2301666318 hasAuthorship W2301666318A5035705032 @default.
• W2301666318 hasAuthorship W2301666318A5045773186 @default.
• W2301666318 hasAuthorship W2301666318A5054435108 @default.
• W2301666318 hasAuthorship W2301666318A5055344816 @default.
• W2301666318 hasAuthorship W2301666318A5065202324 @default.
• W2301666318 hasAuthorship W2301666318A5072543271 @default.
• W2301666318 hasAuthorship W2301666318A5075043769 @default.
• W2301666318 hasAuthorship W2301666318A5075391403 @default.
• W2301666318 hasAuthorship W2301666318A5085753584 @default.
• W2301666318 hasAuthorship W2301666318A5090366405 @default.
• W2301666318 hasBestOaLocation W23016663181 @default.
• W2301666318 hasConcept C126322002 @default.
• W2301666318 hasConcept C141071460 @default.
• W2301666318 hasConcept C143998085 @default.
• W2301666318 hasConcept C203014093 @default.
• W2301666318 hasConcept C2776694085 @default.
• W2301666318 hasConcept C2776755627 @default.
• W2301666318 hasConcept C2777408962 @default.
• W2301666318 hasConcept C2778461978 @default.
• W2301666318 hasConcept C2778729363 @default.
• W2301666318 hasConcept C2779263901 @default.
• W2301666318 hasConcept C2779823535 @default.
• W2301666318 hasConcept C2780611847 @default.
• W2301666318 hasConcept C2781059491 @default.
• W2301666318 hasConcept C2911091166 @default.
• W2301666318 hasConcept C71924100 @default.
• W2301666318 hasConcept C90924648 @default.
• W2301666318 hasConceptScore W2301666318C126322002 @default.
• W2301666318 hasConceptScore W2301666318C141071460 @default.
• W2301666318 hasConceptScore W2301666318C143998085 @default.
• W2301666318 hasConceptScore W2301666318C203014093 @default.
• W2301666318 hasConceptScore W2301666318C2776694085 @default.
• W2301666318 hasConceptScore W2301666318C2776755627 @default.
• W2301666318 hasConceptScore W2301666318C2777408962 @default.
• W2301666318 hasConceptScore W2301666318C2778461978 @default.
• W2301666318 hasConceptScore W2301666318C2778729363 @default.
• W2301666318 hasConceptScore W2301666318C2779263901 @default.
• W2301666318 hasConceptScore W2301666318C2779823535 @default.
• W2301666318 hasConceptScore W2301666318C2780611847 @default.
• W2301666318 hasConceptScore W2301666318C2781059491 @default.
• W2301666318 hasConceptScore W2301666318C2911091166 @default.
• W2301666318 hasConceptScore W2301666318C71924100 @default.
• W2301666318 hasConceptScore W2301666318C90924648 @default.
• W2301666318 hasIssue "3" @default.
• W2301666318 hasLocation W23016663181 @default.
• W2301666318 hasOpenAccess W2301666318 @default.
• W2301666318 hasPrimaryLocation W23016663181 @default.
• W2301666318 hasRelatedWork W2000025145 @default.
• W2301666318 hasRelatedWork W2023136491 @default.
• W2301666318 hasRelatedWork W2144885368 @default.
• W2301666318 hasRelatedWork W2414700771 @default.
• W2301666318 hasRelatedWork W2517815005 @default.
• W2301666318 hasRelatedWork W2560664961 @default.
• W2301666318 hasRelatedWork W2914214895 @default.
• W2301666318 hasRelatedWork W2981208150 @default.
• W2301666318 hasRelatedWork W3032226384 @default.
• W2301666318 hasRelatedWork W3083612802 @default.
• W2301666318 hasVolume "22" @default.
• W2301666318 isParatext "false" @default.
• W2301666318 isRetracted "false" @default.
• W2301666318 magId "2301666318" @default.
• W2301666318 workType "article" @default.